Literature DB >> 16316408

Expression and phosphorylation of TOPK during spermatogenesis.

Taketsugu Fujibuchi1, Yasuhito Abe, Takashi Takeuchi, Norifumi Ueda, Kazuhiro Shigemoto, Haruyasu Yamamoto, Katsumi Kito.   

Abstract

Among normal organs and tissues, the MAPKK-like mitotic protein kinase TOPK is expressed exclusively in the testis. We analyzed the expression and phosphorylation of TOPK to address the functional role of this kinase during spermatogenesis. TOPK protein is expressed mainly in the cytosol of spermatocytes and spermatids, but not in spermatids and spermatogonia in situ. TOPK-Thr-9, a cdk1/cyclin B target residue, was specifically phosphorylated during mitotic and meiotic phases, while TOPK-Thr-198, a key amino acid for the ATP pocket, was constantly phosphorylated irrespective of the cell cycle. These data indicate that spermatogenic germ cells with vital proliferation activity express TOPK. As TOPK-Thr-9 was phosphorylated during both mitosis and meiosis, TOPK was indicted to play a role in cytokinesis and/or chromosomal segregation but not in DNA replication.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 16316408     DOI: 10.1111/j.1440-169X.2005.00834.x

Source DB:  PubMed          Journal:  Dev Growth Differ        ISSN: 0012-1592            Impact factor:   2.053


  15 in total

1.  CDK1-mediated mitotic phosphorylation of PBK is involved in cytokinesis and inhibits its oncogenic activity.

Authors:  Seth Stauffer; Yongji Zeng; Jiuli Zhou; Xingcheng Chen; Yuanhong Chen; Jixin Dong
Journal:  Cell Signal       Date:  2017-08-03       Impact factor: 4.315

2.  TOPK Activation Exerts Protective Effects on Cisplatin-induced Acute Kidney Injury.

Authors:  Hui Zhang; Qing-Qing Dong; Hua-Pan Shu; Yu-Chi Tu; Qian-Qian Liao; Li-Jun Yao
Journal:  Curr Med Sci       Date:  2022-06-09

3.  The design of TOPK inhibitors using structure-based pharmacophore modeling and molecular docking based on an MD-refined homology model.

Authors:  Lara I Fakhouri; Nizar A Al-Shar'i
Journal:  Mol Divers       Date:  2022-01-15       Impact factor: 3.364

4.  Menin-regulated Pbk controls high fat diet-induced compensatory beta cell proliferation.

Authors:  Jian Ma; Bowen Xing; Yan Cao; Xin He; Kate E Bennett; Chao Tong; Chiying An; Taylor Hojnacki; Zijie Feng; Sunbin Deng; Sunbin Ling; Gengchen Xie; Yuan Wu; Yue Ren; Ming Yu; Bryson W Katona; Hongzhe Li; Ali Naji; Xianxin Hua
Journal:  EMBO Mol Med       Date:  2021-04-06       Impact factor: 12.137

5.  PBK/TOPK enhances aggressive phenotype in prostate cancer via β-catenin-TCF/LEF-mediated matrix metalloproteinases production and invasion.

Authors:  Joshua D Brown-Clay; Deepika N Shenoy; Olga Timofeeva; Bhaskar V Kallakury; Asit K Nandi; Partha P Banerjee
Journal:  Oncotarget       Date:  2015-06-20

6.  Targeting PBK/TOPK decreases growth and survival of glioma initiating cells in vitro and attenuates tumor growth in vivo.

Authors:  Mrinal Joel; Awais A Mughal; Zanina Grieg; Wayne Murrell; Sheryl Palmero; Birthe Mikkelsen; Hege B Fjerdingstad; Cecilie J Sandberg; Jinan Behnan; Joel C Glover; Iver A Langmoen; Biljana Stangeland
Journal:  Mol Cancer       Date:  2015-06-17       Impact factor: 27.401

7.  TOPK is highly expressed in circulating tumor cells, enabling metastasis of prostate cancer.

Authors:  Huimin Sun; Lei Zhang; Changhong Shi; Peizhen Hu; Wei Yan; Zhe Wang; Qiuhong Duan; Fan Lu; Lipeng Qin; Tao Lu; Juanjuan Xiao; Yingmei Wang; Feng Zhu; Chen Shao
Journal:  Oncotarget       Date:  2015-05-20

8.  Identification of the oncogenic kinase TOPK/PBK as a master mitotic regulator of C2H2 zinc finger proteins.

Authors:  Raed Rizkallah; Paratchata Batsomboon; Gregory B Dudley; Myra M Hurt
Journal:  Oncotarget       Date:  2015-01-30

9.  Enhanced Expression of the Key Mitosis Regulator Cyclin B1 Is Mediated by PDZ-Binding Kinase in Islets of Pregnant Mice.

Authors:  Tadayoshi Uesato; Takeshi Ogihara; Akemi Hara; Hitoshi Iida; Takeshi Miyatsuka; Yoshio Fujitani; Satoru Takeda; Hirotaka Watada
Journal:  J Endocr Soc       Date:  2018-01-30

10.  TOPK modulates tumour-specific radiosensitivity and correlates with recurrence after prostate radiotherapy.

Authors:  Giacomo Pirovano; Thomas M Ashton; Katharine J Herbert; Richard J Bryant; Clare L Verrill; Lucia Cerundolo; Francesca M Buffa; Remko Prevo; Iona Harrap; Anderson J Ryan; Valentine Macaulay; William G McKenna; Geoff S Higgins
Journal:  Br J Cancer       Date:  2017-07-04       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.